(Q40584258)

21 September 2017

title

The CD8+ T cell repertoire against Her-2/neu antigens in neu transgenic mice is of low avidity with antitumor activity (English)

1 reference

21 September 2017

Joseph Lustgarten

1

1 reference

21 September 2017

Ana Lucia Dominguez

series ordinal

2

1 reference

21 September 2017

Camilo Cuadros

series ordinal

3

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 March 2004

1 reference

European Journal of Immunology

21 September 2017

published in

1 reference

21 September 2017

volume

34

1 reference

21 September 2017

issue

3

1 reference

21 September 2017

page(s)

752-761

1 reference

Structure of the gene of tum- transplantation antigen P91A: the mutated exon encodes a peptide recognized with Ld by cytolytic T cells

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200324427

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200324427

A new era for cancer immunotherapy based on the genes that encode cancer antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200324427

Immune responses to the HLA-A*0201-restricted epitopes of tyrosinase and glycoprotein 100 enable control of melanoma outgrowth in HLA-A*0201-transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200324427

Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200324427

Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200324427

Systemic administration of interleukin 2 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200324427

OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200324427

OX40 ligation enhances primary and memory cytotoxic T lymphocyte responses in an immunotherapy for hepatic colon metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200324427

Identification of Her-2/Neu CTL epitopes using double transgenic mice expressing HLA-A2.1 and human CD.8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200324427

Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200324427

Down regulation of major histocompatibility complex class I expression in mammary carcinoma of HER-2/neu transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200324427

Tolerance to p53 by A2.1-restricted cytotoxic T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200324427

Can the low-avidity self-specific T cell repertoire be exploited for tumor rejection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200324427

Identification and characterization of the immunodominant rat HER-2/neu MHC class I epitope presented by spontaneous mammary tumors from HER-2/neu-transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200324427

Tracing and characterization of the low-avidity self-specific T cell repertoire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200324427

Ox40 costimulation enhances the development of T cell responses induced by dendritic cells in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200324427

Induction of potent antitumor CTL responses by recombinant vaccinia encoding a melan-A peptide analogue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200324427

Levels of peripheral T cell tolerance induced by different doses of tolerogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200324427

Immunological function of a defined T-cell population tolerized to low-affinity self antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200324427

The dual role of IL-2 in the generation and maintenance of CD8+ memory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200324427

Engagement of the OX-40 receptor in vivo enhances antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200324427

21 January 2018

Identifiers

DOI

10.1002/EJI.200324427

1 reference

21 September 2017

1 reference